Anavex Life Sciences Corp (AVXL)

[Bman49ers]

We got to remember here that the original trial design was only 26 weeks of data after the initial 5 weeks. The only reason it was extended to 52 weeks was at the patients and caregivers requests (now extend another 104 weeks/2years after the 52 weeks). The 26 week data is top line data for the FDA and enough to move into phase 2b/3 that's being prepared right now.